{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:57:07Z","timestamp":1789268227817,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,8]],"date-time":"2027-05-08T00:00:00Z","timestamp":1809734400000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100031147","name":"Duke Claude D. Pepper Older Americans Independence Center, Duke Aging Center, Duke University","doi-asserted-by":"publisher","award":["P30AG013679"],"award-info":[{"award-number":["P30AG013679"]}],"id":[{"id":"10.13039\/100031147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG013679"],"award-info":[{"award-number":["P30AG013679"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG060539-05"],"award-info":[{"award-number":["R01AG060539-05"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eprac.2026.01.019","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:18:03Z","timestamp":1769818683000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Testosterone Replacement Therapy in Prostate Cancer Survivors Treated With Radiation With and Without Androgen Deprivation Therapy: A Retrospective Study and Narrative Review"],"prefix":"10.1016","volume":"32","author":[{"given":"Mohan Sonu","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Gagliano-Juc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshaan","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili Valentine","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol M.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalender","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2026.01.019_bib1","first-page":"485","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.019_bib2","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.eprac.2026.01.019_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.eprac.2026.01.019_bib4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.eprac.2026.01.019_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.019_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.eprac.2026.01.019_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.01.019_bib9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/1097-0142(20010515)91:10<1889::AID-CNCR1211>3.0.CO;2-U","article-title":"Hypogonadism following prostate-bed radiation therapy for prostate carcinoma","volume":"91","author":"Daniell","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.019_bib10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0022-5347(05)66910-8","article-title":"A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy","volume":"164","author":"Nejat","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0360-3016(01)02604-9","article-title":"Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer","volume":"52","author":"Padula","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.eprac.2026.01.019_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.acuro.2016.02.010","article-title":"Hormonal changes after localized prostate cancer treatment. Comparison between external beam radiation therapy and radical prostatectomy","volume":"40","author":"Planas","year":"2016","journal-title":"Actas Urol Esp"},{"issue":"8","key":"10.1016\/j.eprac.2026.01.019_bib13","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1210\/jc.2016-1645","article-title":"Testosterone treatment and sexual function in older men with low testosterone levels","volume":"101","author":"Cunningham","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/clinem\/dgad484","article-title":"Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism","volume":"109","author":"Pencina","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.01.019_bib15","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/S2666-7568(23)00169-1","article-title":"Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis","volume":"4","author":"Hudson","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.eprac.2026.01.019_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-00404","article-title":"The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials","author":"Ponce","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.019_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2008.41","article-title":"ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males","volume":"21","author":"Wang","year":"2009","journal-title":"Int J Impot Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.019_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5694\/mja16.00448","article-title":"Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations","volume":"205","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.eprac.2026.01.019_bib20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jsxm.2021.06.007","article-title":"Trends in testosterone therapy use in prostate cancer survivors in the United States","volume":"18","author":"Chen","year":"2021","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.019_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41391-020-0241-3","article-title":"Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease","volume":"23","author":"Sarkar","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.eprac.2026.01.019_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies","volume":"100","author":"Endogenous","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.eprac.2026.01.019_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48692","article-title":"Prostate safety events during testosterone replacement therapy in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Bhasin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.eprac.2026.01.019_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2026.01.019_bib25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/clinem\/dgae334","article-title":"Prostate risk and monitoring during testosterone replacement therapy","volume":"109","author":"Bhasin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.01.019_bib26","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.019_bib28","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2005-07-3046","article-title":"The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?","volume":"107","author":"Beutler","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.eprac.2026.01.019_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40030","article-title":"Efficacy of testosterone replacement therapy in correcting anemia in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Pencina","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.eprac.2026.01.019_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cncr.22438","article-title":"Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy","volume":"109","author":"Sarosdy","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2008.07882.x","article-title":"Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations","volume":"103","author":"Morales","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.eprac.2026.01.019_bib32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2015.05.084","article-title":"Testosterone therapy after radiation therapy for low, intermediate and high risk prostate cancer","volume":"194","author":"Pastuszak","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bju.12668","article-title":"Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer","volume":"114","author":"Balbontin","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5534\/wjmh.180130","article-title":"Testosterone replacement therapy for patients with hypogonadism after high dose-rate brachytherapy for high-risk prostate cancer: a report of six cases and literature review","volume":"38","author":"Kadomoto","year":"2020","journal-title":"World J Mens Health"},{"issue":"4S","key":"10.1016\/j.eprac.2026.01.019_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-5347(08)61255-0","article-title":"Testosterone replacement therapy for hypogonadal men with a history of prostate cancer","volume":"179","author":"Davila","year":"2008","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1008-682X.160270","article-title":"Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results","volume":"18","author":"Kacker","year":"2016","journal-title":"Asian J Androl"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.019_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.juro.2016.04.069","article-title":"Testosterone therapy in patients with treated and untreated prostate cancer: impact on oncologic outcomes","volume":"196","author":"Ory","year":"2016","journal-title":"J Urol"},{"issue":"4S","key":"10.1016\/j.eprac.2026.01.019_bib38","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.juro.2018.02.558","article-title":"Recurrence rates following testostereone therapy in a large clinical cohort of men with prostate cancer","volume":"199","author":"Morgentaler","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.21037\/tau-24-422","article-title":"Testosterone therapy in patients with locoregional prostate cancer treated with prior androgen deprivation therapy and radiation: a retrospective single center review","volume":"14","author":"Aglan","year":"2025","journal-title":"Transl Androl Urol"},{"issue":"9","key":"10.1016\/j.eprac.2026.01.019_bib40","article-title":"Clinical oncological tolerance of testosterone replacement therapy over two years among patients with high-risk or very high-risk prostate cancer undergoing radiotherapy","volume":"17","author":"Shigehara","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.eprac.2026.01.019_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ijir.2012.29","article-title":"Testosterone replacement therapy in the setting of prostate cancer treated with radiation","volume":"25","author":"Pastuszak","year":"2013","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jsm.12768","article-title":"Testosterone replacement therapy in men with prostate cancer: a time-varying analysis","volume":"12","author":"Kaplan","year":"2015","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.01.019_bib43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.juro.2010.11.084","article-title":"Testosterone therapy in men with untreated prostate cancer","volume":"185","author":"Morgentaler","year":"2011","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.eprac.2026.01.019_bib44","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.urolonc.2023.06.002","article-title":"Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?","volume":"41","author":"Daza","year":"2023","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2026.01.019_bib45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/jsxmed\/qdaf003","article-title":"Testosterone replacement therapy in men on active surveillance for prostate cancer","volume":"22","author":"Applewhite","year":"2025","journal-title":"J Sex Med"},{"key":"10.1016\/j.eprac.2026.01.019_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euros.2024.01.005","article-title":"Oncologic outcomes of testosterone therapy for men on active surveillance for prostate cancer: a population-based analysis","volume":"60","author":"Kaplan-Marans","year":"2024","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.019_bib47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMra2404637","article-title":"Testosterone treatment in middle-aged and older men with hypogonadism","volume":"393","author":"Bhasin","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.019_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/10742484211027394","article-title":"Effects of a novel oral testosterone undecanoate on ambulatory blood pressure in hypogonadal men","volume":"26","author":"White","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2026.01.019_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003901","article-title":"Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates","volume":"4","author":"Watts","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.eprac.2026.01.019_bib51","first-page":"1761","article-title":"The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature","volume":"21","author":"Langston","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.eprac.2026.01.019_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2005.06.006","article-title":"Sexual function after external-beam radiotherapy for prostate cancer: what do we know?","volume":"57","author":"Incrocci","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.eprac.2026.01.019_bib53","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgae026","article-title":"Depressive syndromes in men with hypogonadism in the TRAVERSE trial: response to testosterone-replacement therapy","volume":"109","author":"Bhasin","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:57:28Z","timestamp":1784530648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1530891X26000364"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.01.019","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone Replacement Therapy in Prostate Cancer Survivors Treated With Radiation With and Without Androgen Deprivation Therapy: A Retrospective Study and Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}